In 2003, the United States Congressional Research Service asserted that there is a danger that India may develop a bio weapons programme. It claimed that 'India is believed to have an active......
The life sciences industry in Asia clocked a growth of 3.4 per cent to record revenues of $110.89 billion in the calendar year 2009, with nearly half the revenues -- $54.24 billion -- coming from......
Hari S Bhartia, co-chairman & managing director of Jubilant Organosys Ltd, has been elected as the president of the Confederation of Indian Industry for the year 2010-11. He succeeds Venu......
An industry-friendly regulatory mechanism for biotech sector would be put in place by November, Kapil Sibal, Union Minister for Science and Technology, said. In his keynote address at Biotech CEO......
Mumbai outpaced Bangalore, with a margin of about Rs 200 crore (Rs 2 billion), to become India's top biotech city in terms of revenue while Bangalore-based bio pharmaceuticals major Biocon clocked......
Most of the biotech companies are focusing on discovery-led innovation in biopharmaceuticals. The segment has been witnessing innovations in follow-on (new variants) biologics (commercial products......